Neurogene Inc. - Common Stock (NGNE)

Historical Holders from Q4 2023 to Q3 2025

Symbol
NGNE on Nasdaq
CUSIP
64135M105
Type / Class
Equity / Common Stock
Shares outstanding
14.6M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
15.3M
Holdings value
$265M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
87
Number of buys
38
Number of sells
-36
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Neurogene Inc. - Common Stock (NGNE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RTW INVESTMENTS, LP 9.99% $16.5M 1.5M RTW Investments, LP Dec 31, 2024
Redmile Group, LLC 9.9% $16.3M 1.48M Redmile Group, LLC Dec 31, 2024
EcoR1 Capital, LLC 9.9% $25M 1.44M EcoR1 Capital, LLC Sep 30, 2025
Casdin Capital, LLC 8.7% $14.2M 1.3M Casdin Capital, LLC Dec 31, 2024
BlackRock, Inc. 6.8% $11.1M 1.01M BlackRock, Inc. Mar 31, 2025
BAKER BROS. ADVISORS LP 7% -29.6% $18.7M -$9.32M 992K -33.3% Julian C. Baker Jun 30, 2025
FMR LLC 3.1% $5.09M 463K FMR LLC Mar 31, 2025
GREAT POINT PARTNERS LLC 2.98% $4.87M 443K Great Point Partners, LLC Dec 31, 2024
Commodore Capital LP 3% $8.06M 428K Commodore Capital LP Jun 30, 2025

Institutional Holders of Neurogene Inc. - Common Stock (NGNE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 15.3M $265M -$165K $17.33 87
2025 Q2 15.4M $230M -$13.6M $14.95 81
2025 Q1 16.5M $193M +$734K $11.71 83
2024 Q4 16.1M $368M +$14.5M $22.86 86
2024 Q3 13.8M $581M +$18M $41.96 85
2024 Q2 13.3M $483M +$37.4M $36.39 66
2024 Q1 12.1M $617M +$144M $50.90 58
2023 Q4 9.23M $179M +$172M $19.38 35